Forecast Period 
Market Size (Base Year) 
Market Size (Forecast Year)
CAGREurope Endoscopic Retrograde Cholangiopancreatography Devices Market, By Product Type (Endotherapy Devices, Endoscopes, Imaging Devices, and Others), Modality (Single Use, Standalone, Handheld), Procedure (Biliary Sphicterectomy, Biliary Stenting, Biliary Dilation, Pancreatic Duct Stenting, Pancreatic Sphicterectomy), Application (Bile Duct, Pancreas, Gall Bladder, Liver and Others), End User(Hospitals, Ambulatory Surgical Center, Diagnostic Laboratories and Others), Facility Type (Large, Medium and Small), Distribution Channel (Direct Tenders, Third Party Distribution, and Retail Sales), Country (Germany, France, U.K., Hungary, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe) Industry Trends and Forecast 2028.
Market Analysis and Insights: Europe Endoscopic Retrograde Cholangiopancreatography Devices Market
The Europe endoscopic retrograde cholangiopancreatography devices market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.4% in the forecast period of 2021 to 2028 and is expected to reach USD 815.43 million by 2028 from USD 552.96 million in 2020. The high prevalence of pancreatic and biliary diseases is likely to be the major driver that propels the market's demand in the forecast period.
The high prevalence of pancreatic and biliary diseases, established healthcare infrastructure, adoption of advanced technology by market players among other factors are driving the growth of the market in European region. However, the high cost of medical devices may restrain the growth of ERCP devices market. The increasing awareness of people towards their health and fitness is acting as opportunity for the growth of the market. The side effects associated with procedure may act as challenge for the market.
The Europe endoscopic retrograde cholangiopancreatography devices market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.
Europe Endoscopic Retrograde Cholangiopancreatography Devices Market Scope and Market Size
Europe endoscopic retrograde cholangiopancreatography devices market is categorized into seven notable segments which are based on product type, modality, procedure, application, end user, facility type, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product type, Europe endoscopic retrograde cholangiopancreatography devices market is segmented into endotherapy devices, endoscopes, imaging devices, and others. In 2021, endotherapy devices segment is expected to dominate the market due to the availability of various types of equipment, and big players are manufacturing this equipment in the European market.
- On the basis of modality, Europe endoscopic retrograde cholangiopancreatography devices market is segmented into single-use, standalone, and handheld. In 2021, the single-use segment is expected to dominate the market because there is no risk of disease transmission from one patient to another while using single-use devices.
- On the basis of procedure, Europe endoscopic retrograde cholangiopancreatography devices market is segmented into biliary sphincterotomy, biliary stenting, biliary dilation, pancreatic duct stenting, and pancreatic sphincterotomy. In 2021, the biliary sphincterotomy segment is expected to dominate the market because of the high prevalence of pancreatic tumors in the European region.
- On the basis of application, Europe endoscopic retrograde cholangiopancreatography devices market is segmented into the bile duct, pancreas, gall bladder, liver, and others. In 2021, the bile duct segment is expected to dominate the market because of the high prevalence of biliary diseases across the European region.
- On the basis of end user, Europe endoscopic retrograde cholangiopancreatography devices market is segmented into hospitals, ambulatory surgical centers, diagnostic laboratories, and others. In 2021, the hospital's segment is expected to dominate the market due to the growing emphasis on strategic initiatives (such as acquisitions, partnerships, and collaborations) by medical device companies to expand their capabilities in the Europe endoscopic retrograde cholangiopancreatography devices market.
- On the basis of facility type, Europe endoscopic retrograde cholangiopancreatography devices market is segmented into large, medium, and small. In 2021, the large segment is expected to dominate the market due to the high demand for ERCP procedures in Europe.
- On the basis of distribution channel, Europe endoscopic retrograde cholangiopancreatography devices market is segmented into direct tenders, third party distribution, and retail sales. In 2021, the direct tender segment is expected to dominate the market because of significant growth due to the overall control over sales and revenue processes and direct interactions with customers.
Europe Endoscopic Retrograde Cholangiopancreatography Devices Market Country Level Analysis
The Europe endoscopic retrograde cholangiopancreatography devices market is analyzed, and market size information is provided by product type, modality, procedure, applications, end-user, facility type, and distribution.
The countries covered in the Europe endoscopic retrograde cholangiopancreatography devices market report are Germany, France, Italy, the U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, Rest of Europe
Europe is expected to grow with a CAGR of 5.4% in the forecasted periods as in the European countries; the demand for ERCP devices is increasing very rapidly with increasing healthcare infrastructure. Germany is expected to dominate in the market in Europe market owing to advanced healthcare infrastructure and big players are operating in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of European brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
The Presence of Advanced Technology and Strategic Initiatives Taken by Players are Creating New Opportunities In The Europe Endoscopic Retrograde Cholangiopancreatography Devices Market
Europe endoscopic retrograde cholangiopancreatography devices market provides you with detailed market analysis for every country's growth in a particular industry with ERCP products sales, the impact of advancement in the market, and changes in regulatory scenarios with their support for the market. The data is available for the historical period 2010 to 2019.
Competitive Landscape and Europe Endoscopic Retrograde Cholangiopancreatography Devices Market Share Analysis
Europe endoscopic retrograde cholangiopancreatography devices market competitive landscape provide details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points are only related to the company's focus on the endoscopic retrograde cholangiopancreatography devices market.
The major companies providing the Europe endoscopic retrograde cholangiopancreatography devices are Olympus Corporation, Boston Scientific Corporation, Medtronic, BD, Ambu Inc., CONMED Corporation, HOBBS MEDICAL, INC., FUJIFILM Corporation, TeleMed Systems, Inc., Merit Medical Systems, Cook, KARL STORZ SE & Co. KG, Johnson & Johnson Services, Inc., HOYA Corporation, Medi-Globe GmbH, STERIS, Shaili Endoscopy, Hospiline Equipments among others.
DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The strategic initiatives by market players and new technological advancements for endoscopic retrograde cholangiopancreatography devices are bridging the gap for a variety of treatments.
For instance,
- In May 2018, Olympus Corporation, entered into an co-development agreement with ai4gi Solutions Inc. This agreement aims to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients
- In January 2021, Boston Scientific Corporation announced that it has entered into an agreement to acquire Preventice Solutions, Inc. The acquisition will help the company to expand its portfolio
Collaboration, joint ventures, and other strategies by the market player are enhancing the company market in the endoscopic retrograde cholangiopancreatography devices market, which also benefits the organization to improve their offering for the endoscopic retrograde cholangiopancreatography devices market.
